• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

KRAS 突变通过下调 SERTAD4 促进具核梭杆菌在结直肠癌中的定植。

KRAS mutation promotes the colonization of Fusobacterium nucleatum in colorectal cancer by down-regulating SERTAD4.

机构信息

Department of Geriatric Medicine, Fujian Key Laboratory of Geriatrics Diseases, Fujian Provincial Center for Geriatrics, Fujian Provincial Hospital, Fuzhou University Affiliated Provincial Hospital, School of Medicine, Fuzhou University, Fuzhou, Fujian, China.

Shengli Clinical Medical College of Fujian Medical University, Fuzhou, Fujian, China.

出版信息

J Cell Mol Med. 2024 Oct;28(20):e70182. doi: 10.1111/jcmm.70182.

DOI:10.1111/jcmm.70182
PMID:39462261
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11512757/
Abstract

This study explores and verifies potential molecular targets through which KRAS mutations regulate the colonization of Fusobacterium nucleatum (FN) in colorectal cancer (CRC). This study combined multiple bioinformatics methods and biological assays. Through The Cancer Genome Atlas, Gene Expression Omnibus, Human Protein Atlas, immunohistochemistry, and co-culture assays, we further confirmed the differential expression of SERTAD4 in CRC. We delved deeper into examining how expression of SERTAD4 is linked with immune cell infiltration and the enrichment of potential pathways. Lastly, through bacterial phenotypic assays, we validated the function of SERTAD4. As a molecule associated with KRAS mutations and FN infection, the expression levels of SERTAD4 were downregulated in CRC. The diagnostic efficacy of SERTAD4 for CRC is not inferior to that of CEA. Low expression of SERTAD4 is associated with poorer overall survival in CRC. Correlation analysis found that increased expression of SERTAD4 is associated with various immune cell infiltrations and immune checkpoint genes. Finally, bacterial adhesion and invasion assays verify that SERTAD4 inhibits the adhesion and invasion abilities of FN in CRC. This study demonstrates that SERTAD4 exerts a protective role in CRC by inhibiting the colonization of FN.

摘要

本研究通过探索和验证潜在的分子靶点,研究 KRAS 突变如何调节具核梭杆菌(FN)在结直肠癌(CRC)中的定植。本研究结合了多种生物信息学方法和生物学检测。通过癌症基因组图谱、基因表达综合数据库、人类蛋白质图谱、免疫组织化学和共培养检测,我们进一步证实了 SERTAD4 在 CRC 中的差异表达。我们深入研究了 SERTAD4 的表达如何与免疫细胞浸润和潜在通路的富集相关联。最后,通过细菌表型检测,我们验证了 SERTAD4 的功能。作为与 KRAS 突变和 FN 感染相关的分子,SERTAD4 的表达水平在 CRC 中下调。SERTAD4 对 CRC 的诊断效能并不逊于 CEA。SERTAD4 的低表达与 CRC 患者总体生存率较差相关。相关性分析发现,SERTAD4 的高表达与各种免疫细胞浸润和免疫检查点基因相关。最后,细菌黏附和侵袭实验验证了 SERTAD4 抑制 CRC 中 FN 的黏附和侵袭能力。本研究表明,SERTAD4 通过抑制 FN 的定植在 CRC 中发挥保护作用。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ae60/11512757/00bfb972a8aa/JCMM-28-e70182-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ae60/11512757/df9fb30614de/JCMM-28-e70182-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ae60/11512757/58ac84f9c8e3/JCMM-28-e70182-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ae60/11512757/d101b085c214/JCMM-28-e70182-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ae60/11512757/0b223bccfab6/JCMM-28-e70182-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ae60/11512757/22a422beb6a0/JCMM-28-e70182-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ae60/11512757/e163bd852e79/JCMM-28-e70182-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ae60/11512757/5be7ef10eeb2/JCMM-28-e70182-g009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ae60/11512757/ca1eca01d4e9/JCMM-28-e70182-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ae60/11512757/00bfb972a8aa/JCMM-28-e70182-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ae60/11512757/df9fb30614de/JCMM-28-e70182-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ae60/11512757/58ac84f9c8e3/JCMM-28-e70182-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ae60/11512757/d101b085c214/JCMM-28-e70182-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ae60/11512757/0b223bccfab6/JCMM-28-e70182-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ae60/11512757/22a422beb6a0/JCMM-28-e70182-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ae60/11512757/e163bd852e79/JCMM-28-e70182-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ae60/11512757/5be7ef10eeb2/JCMM-28-e70182-g009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ae60/11512757/ca1eca01d4e9/JCMM-28-e70182-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ae60/11512757/00bfb972a8aa/JCMM-28-e70182-g001.jpg

相似文献

1
KRAS mutation promotes the colonization of Fusobacterium nucleatum in colorectal cancer by down-regulating SERTAD4.KRAS 突变通过下调 SERTAD4 促进具核梭杆菌在结直肠癌中的定植。
J Cell Mol Med. 2024 Oct;28(20):e70182. doi: 10.1111/jcmm.70182.
2
Fusobacterium nucleatum as a prognostic marker of colorectal cancer in a Japanese population.具核梭杆菌作为日本人群结直肠癌的预后标志物。
J Gastroenterol. 2018 Apr;53(4):517-524. doi: 10.1007/s00535-017-1382-6. Epub 2017 Aug 19.
3
Relationship between , inflammatory mediators and microRNAs in colorectal carcinogenesis.在结直肠癌发生过程中 、炎症介质和 microRNAs 之间的关系。
World J Gastroenterol. 2018 Dec 21;24(47):5351-5365. doi: 10.3748/wjg.v24.i47.5351.
4
Fusobacterium nucleatum Increases Proliferation of Colorectal Cancer Cells and Tumor Development in Mice by Activating Toll-Like Receptor 4 Signaling to Nuclear Factor-κB, and Up-regulating Expression of MicroRNA-21.具核梭杆菌通过激活Toll样受体4信号传导至核因子κB并上调微小RNA-21的表达来增加结肠直肠癌细胞的增殖和小鼠肿瘤的发展。
Gastroenterology. 2017 Mar;152(4):851-866.e24. doi: 10.1053/j.gastro.2016.11.018. Epub 2016 Nov 19.
5
Association Between Fusobacterium nucleatum, Pathway Mutation, and Patient Prognosis in Colorectal Cancer.具核梭杆菌与通路突变及其与结直肠癌患者预后的关联
Ann Surg Oncol. 2018 Oct;25(11):3389-3395. doi: 10.1245/s10434-018-6681-5. Epub 2018 Jul 30.
6
Replication Study: infection is prevalent in human colorectal carcinoma.复制研究:感染在人结直肠癌细胞中普遍存在。
Elife. 2018 Mar 13;7:e25801. doi: 10.7554/eLife.25801.
7
Fusobacterium nucleatum associates with stages of colorectal neoplasia development, colorectal cancer and disease outcome.具核梭杆菌与结直肠癌发生发展阶段、结直肠癌及疾病转归相关。
Eur J Clin Microbiol Infect Dis. 2014 Aug;33(8):1381-90. doi: 10.1007/s10096-014-2081-3. Epub 2014 Mar 6.
8
Fusobacterium nucleatum upregulates MMP7 to promote metastasis-related characteristics of colorectal cancer cell via activating MAPK(JNK)-AP1 axis.具核梭杆菌通过激活 MAPK(JNK)-AP1 轴上调 MMP7 促进结直肠癌细胞的转移相关特征。
J Transl Med. 2023 Oct 9;21(1):704. doi: 10.1186/s12967-023-04527-3.
9
The adhesin RadD enhances Fusobacterium nucleatum tumour colonization and colorectal carcinogenesis.黏附素 RadD 增强具核梭杆菌的肿瘤定植和结直肠癌变。
Nat Microbiol. 2024 Sep;9(9):2292-2307. doi: 10.1038/s41564-024-01784-w. Epub 2024 Aug 21.
10
Fusobacterium nucleatum induces oxaliplatin resistance by inhibiting ferroptosis through E-cadherin/β-catenin/GPX4 axis in colorectal cancer.具核梭杆菌通过 E-钙黏蛋白/β-连环蛋白/谷胱甘肽过氧化物酶 4 轴抑制铁死亡诱导结直肠癌细胞对奥沙利铂耐药。
Free Radic Biol Med. 2024 Aug 1;220:125-138. doi: 10.1016/j.freeradbiomed.2024.04.226. Epub 2024 Apr 22.

引用本文的文献

1
Bacterial Extracellular Vesicles in Oncology: Molecular Mechanisms and Future Clinical Applications.肿瘤学中的细菌细胞外囊泡:分子机制与未来临床应用
Cancers (Basel). 2025 May 26;17(11):1774. doi: 10.3390/cancers17111774.
2
Cuproptosis-related gene ACAD8 inhibits the metastatic ability of colorectal cancer by inducing cuproptosis.铜死亡相关基因ACAD8通过诱导铜死亡抑制结直肠癌的转移能力。
Front Immunol. 2025 Apr 3;16:1560322. doi: 10.3389/fimmu.2025.1560322. eCollection 2025.

本文引用的文献

1
Bioinformatics analysis and experimental verification of the cancer-promoting effect of DHODH in clear cell renal cell carcinoma.生物信息学分析和实验验证 DHODH 在透明细胞肾细胞癌中的促癌作用。
Sci Rep. 2024 May 25;14(1):11985. doi: 10.1038/s41598-024-62738-0.
2
Fusobacterium nucleatum carcinogenesis and drug delivery interventions.具核梭杆菌致癌作用与药物递送干预。
Adv Drug Deliv Rev. 2024 Jun;209:115319. doi: 10.1016/j.addr.2024.115319. Epub 2024 Apr 21.
3
ITPRIPL1 binds CD3ε to impede T cell activation and enable tumor immune evasion.
ITPRIPL1 通过结合 CD3ε 抑制 T 细胞激活并促进肿瘤免疫逃逸。
Cell. 2024 Apr 25;187(9):2305-2323.e33. doi: 10.1016/j.cell.2024.03.019. Epub 2024 Apr 12.
4
A distinct Fusobacterium nucleatum clade dominates the colorectal cancer niche.一种独特的具核梭杆菌(Fusobacterium nucleatum)分支在结直肠癌生态位中占据主导地位。
Nature. 2024 Apr;628(8007):424-432. doi: 10.1038/s41586-024-07182-w. Epub 2024 Mar 20.
5
Microbial metabolite enhances immunotherapy efficacy by modulating T cell stemness in pan-cancer.微生物代谢产物通过调节泛癌中的 T 细胞干性增强免疫疗法疗效。
Cell. 2024 Mar 28;187(7):1651-1665.e21. doi: 10.1016/j.cell.2024.02.022. Epub 2024 Mar 14.
6
Integrated Bioinformatics Analysis Identified ASNS and DDIT3 as the Therapeutic Target in Castrate-Resistant Prostate Cancer.综合生物信息学分析确定ASNS和DDIT3为去势抵抗性前列腺癌的治疗靶点。
Int J Mol Sci. 2024 Feb 29;25(5):2836. doi: 10.3390/ijms25052836.
7
Current advances in targeted therapy for metastatic colorectal cancer - Clinical translation and future directions.转移性结直肠癌靶向治疗的最新进展——临床转化与未来方向。
Cancer Treat Rev. 2024 Apr;125:102700. doi: 10.1016/j.ctrv.2024.102700. Epub 2024 Feb 24.
8
Th17 Cells Secrete TWEAK to Trigger Epithelial-Mesenchymal Transition and Promote Colorectal Cancer Liver Metastasis.辅助性T细胞17分泌肿瘤坏死因子样弱凋亡诱导因子以触发上皮-间质转化并促进结直肠癌肝转移。
Cancer Res. 2024 Apr 15;84(8):1352-1371. doi: 10.1158/0008-5472.CAN-23-2123.
9
Cancer statistics, 2024.2024年癌症统计数据。
CA Cancer J Clin. 2024 Jan-Feb;74(1):12-49. doi: 10.3322/caac.21820. Epub 2024 Jan 17.
10
Bioinformatics analysis of CMTM family in pan-cancer and preliminary exploration of CMTM6 in bladder cancer.CMTM 家族在泛癌中的生物信息学分析及 CMTM6 在膀胱癌中的初步探索。
Cell Signal. 2024 Mar;115:111012. doi: 10.1016/j.cellsig.2023.111012. Epub 2023 Dec 17.